home / stock / ango / ango news


ANGO News and Press, AngioDynamics Inc. From 05/13/19

Stock Information

Company Name: AngioDynamics Inc.
Stock Symbol: ANGO
Market: NASDAQ
Website: angiodynamics.com

Menu

ANGO ANGO Quote ANGO Short ANGO News ANGO Articles ANGO Message Board
Get ANGO Alerts

News, Short Squeeze, Breakout and More Instantly...

ANGO - AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced enrollment of the first patient in its NanoKnife ® Irreversible Electroporation (IRE) “ D at...

ANGO - Varian Acquires CyberHeart For Cardiac Radioablation Tech

Quick Take Varian ( VAR ) announced it has acquired CyberHeart for an undisclosed amount. CyberHeart has intellectual property that covers cardiac radioablation - the use of radiation to scar or destroy tissue in the heart that is facilitating faulty electrical signals, causing an abnorm...

ANGO - AngioDynamics down 6% on revised guidance

AngioDynamics ( ANGO -5.6% ) slips on average volume in early trade on the heels of revised guidance accounting for the divestment of its NAMIC unit to Medline Industries announced yesterday. More news on: AngioDynamics, Inc., Healthcare stocks news, Stocks on the move, Read more...

ANGO - AngioDynamics to sell NAMIC business for $167.5M

AngioDynamics (NASDAQ: ANGO ) has agreed to sel l its NAMIC fluid management line to Medline Industries for $167.5M. More news on: AngioDynamics, Inc., Healthcare stocks news, Merger & acquisition news, Read more ...

ANGO - AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million

AngioDynamics to host conference call today at 5:00 p.m. ET AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for oncology, vascular access, and peripheral vascular disease, today announced that it has entered into a definitive ...

ANGO - AngioDynamics' DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that the Company received central Institutional Review Board (IRB) approval to conduct its NanoKnife ® ...

ANGO - AngioDynamics (ANGO) Presents At 18th Annual Needham Healthcare Conference - Slideshow

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more ...

ANGO - AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q3 2019 Results - Earnings Call Transcript

AngioDynamics, Inc. (ANGO) Q3 2019 Results Earnings Conference Call April 02, 2019, 08:00 AM ET Company Participants Jim Clemmer - President and Chief Executive Officer Michael Greiner - Executive Vice President and Chief Financial Officer Stephen Trowbridge - Senior Vice Preside...

ANGO - Dow Slips Following Monday Hike

Stocks fell on Tuesday as investors digested a strong rally from the previous session, while a decline in Walgreens Boots Alliance shares also dampened sentiment. The Dow Jones Industrials slumped 78.46 points to 26,179.96, as Walgreens lagged. The S&P 500 handed back 1.13 points...

ANGO - AngioDynamics, Inc. 2019 Q3 - Results - Earnings Call Slides

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2019 Q3 earnings Read more ...

Previous 10 Next 10